Clinical Relevance of the Determination of IgM in the Cerebrospinal Fluid with Special Reference to Multiple Sclerosis Patients

  • C. Sindic
  • C. L. Cambiaso
  • P. L. Masson
  • E. C. Laterre


The determination of plasma proteins in cerebrospinal fluid (CSF) enables us to assess the filtration process through the blood-brain barrier. Their increase generally indicates the existence of an inflammatory reaction in neurological tissues. Particular attention has been paid to IgG because of its possible local origin, and its determination is now fairly common. On a theoretical basis, the determination of IgM in CSF should be more useful than that of IgG. Because IgM is less liable to gain access to CSF by mere transudation on account of its large molecular size, an increase in IgM concentration should be a better index of the local immune response. Moreover, IgM should become detectable at earlier stages of the immune process, as it is generally the first antibody to be produced. However, in practive, the determination of IgM in CSF is not easy, as it requires very sensitive methods.


Multiple Sclerosis Multiple Sclerosis Patient Severe Combine Immunodeficiency Oligoclonal Band Local Immune Response 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cambiaso CL, Leek AE, de Steenwinkel F, Billen J, Masson PL (1978) Particle Counting Immunoassay (PACIA). I. — A general method for the determination of antibodies, antigens and haptens. J Immunol Methods 18:33–44CrossRefGoogle Scholar
  2. 2.
    Rádl J, van den Berg P, Voormolen M, Hendriks WDH, Schaefer UW (1974) Homogeneous immunoglobulins in sera of Rhesus monkeys after lethal irradiation and bone-marrow transplantation. Clin Exp Immunol 16:259–266Google Scholar
  3. 3.
    Rádl J, Dooren LJ, Eijsvoogel VP, van Went JJ, Hijmans W (1972) An immunological study during post-transplantation follow-up of a case of severe combined immunodeficiency. Clin Exp Immunol 10:367–382PubMedGoogle Scholar
  4. 4.
    Schuller E, Delasnerie N, Hélary M, Lefevre M (1978) Serum and cerebrospinal fluid IgM in 203 neurological patients. Eur Neurol 17:77–82PubMedCrossRefGoogle Scholar
  5. 5.
    Williams AC, Mingioli ES, McFarland H, Tourtellotte WW, McFarlin DE (1978) Elevated CSF IgM in multiple sclerosis. Neurology (Minneap) 28:393Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • C. Sindic
  • C. L. Cambiaso
  • P. L. Masson
  • E. C. Laterre
    • 1
  1. 1.Unit of Experimental Medicine, International Institute of Cellular, Molecular Pathology, Laboratory of NeurochemistryUniversity of LouvainBrusselsBelgium

Personalised recommendations